These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33100796)
1. A retrospective study on therapeutic drug monitoring of mood stabilizers in real-life clinical scenario. Abu-Qurain H; Almashhad F; Lucca JM; Abumadini MS J Pharm Bioallied Sci; 2020; 12(3):351-355. PubMed ID: 33100796 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. Deligiannidis KM; Byatt N; Freeman MP J Clin Psychopharmacol; 2014 Apr; 34(2):244-55. PubMed ID: 24525634 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India. Sharma S; Joshi S; Chadda RK Am J Ther; 2009; 16(5):393-7. PubMed ID: 19262359 [TBL] [Abstract][Full Text] [Related]
4. Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology. Hiemke C Curr Drug Deliv; 2016; 13(3):353-61. PubMed ID: 26511090 [TBL] [Abstract][Full Text] [Related]
5. Appropriateness of therapeutic drug monitoring for lithium. Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880 [TBL] [Abstract][Full Text] [Related]
7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
8. General pharmacokinetic/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder. Ware K; Tillery E; Linder L Ment Health Clin; 2016 Jan; 6(1):54-61. PubMed ID: 29955448 [TBL] [Abstract][Full Text] [Related]
9. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. Rybakowski JK CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337 [TBL] [Abstract][Full Text] [Related]
10. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes. Biso L; Aringhieri S; Carli M; Scarselli M; Longoni B Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794212 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises? Hiemke C Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():21-7. PubMed ID: 18344046 [TBL] [Abstract][Full Text] [Related]
13. Association between mood-stabilizing medication and mental health resource use in the management of acute mania. Sajatovic M; Gerhart C; Semple W Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. Marcus SC; Olfson M; Pincus HA; Zarin DA; Kupfer DJ Am J Psychiatry; 1999 Jul; 156(7):1014-8. PubMed ID: 10401444 [TBL] [Abstract][Full Text] [Related]
15. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients. Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664 [TBL] [Abstract][Full Text] [Related]
16. Use of lithium, carbamazepine, and valproic acid in a state-operated psychiatric hospital. Citrome L J Pharm Technol; 1995; 11(2):55-9. PubMed ID: 10141967 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514 [TBL] [Abstract][Full Text] [Related]
18. Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients. Perrone V; Cattaneo D; Radice S; Sangiorgi D; Federici AB; Gismondo MR; Medaglia M; Micheli V; Vimercati S; Pallone E; Degli Esposti L; Clementi E Clinicoecon Outcomes Res; 2014; 6():341-8. PubMed ID: 25053888 [TBL] [Abstract][Full Text] [Related]
19. French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs. Rougemont M; Ulrich S; Hiemke C; Corruble E; Baumann P Fundam Clin Pharmacol; 2010 Jun; 24(3):377-84. PubMed ID: 20199581 [TBL] [Abstract][Full Text] [Related]
20. Utilization of antipsychotic therapeutic drug monitoring at a state psychiatric hospital. Wong KR; Nelson LA; Elliott ESR; Liu Y; Sommi RW; Winans EA Ment Health Clin; 2016 Jan; 6(1):1-7. PubMed ID: 29955441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]